Imaging of lung cancer with fluorine-18 fluorodeoxyglucose: comparison of a dual-head gamma camera in coincidence mode with a full-ring positron emission tomography system
暂无分享,去创建一个
Peter Bartenstein | Wolfgang A. Weber | H. W. Präuer | Jodi Neverve | Sybille Ziegler | H Lichte | M. Schwaiger | P. Bartenstein | W. Weber | H. Lichte | S. Ziegler | T. Treumann | W. Weber | M. Schwaiger | J Sklarek | Brian King | T. Treumann | A Enterrottacher | M Krapf | Ke Häussinger | O Thetter | J. Neverve | J. Sklarek | B. King | A. Enterrottacher | M. Krapf | K. Häussinger | H. Präuer | O. Thetter | P. Bartenstein
[1] K. Hamacher,et al. Efficient stereospecific synthesis of no-carrier-added 2-[18F]-fluoro-2-deoxy-D-glucose using aminopolyether supported nucleophilic substitution. , 1986, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[2] S Sone,et al. The number and size of normal mediastinal lymph nodes: a postmortem study. , 1988, AJR. American journal of roentgenology.
[3] R Iwata,et al. Differential diagnosis of lung tumor with positron emission tomography: a prospective study. , 1990, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[4] B. Gross,et al. Can computed tomography of the chest stage lung cancer? Yes and no. , 1990, The Annals of thoracic surgery.
[5] L G Strauss,et al. The applications of PET in clinical oncology. , 1991, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[6] E H Moore,et al. Bronchogenic carcinoma: analysis of staging in the mediastinum with CT by correlative lymph node mapping and sampling. , 1992, Radiology.
[7] S Grootoonk,et al. Performance Evaluation of the Positron Scanner ECAT EXACT , 1992, Journal of computer assisted tomography.
[8] Scott T. Grafton,et al. Results of a clinical receiver operating characteristic study comparing filtered backprojection and maximum likelihood estimator images in FDG PET studies. , 1993, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[9] R. Coleman,et al. Focal pulmonary abnormalities: evaluation with F-18 fluorodeoxyglucose PET scanning. , 1993, Radiology.
[10] M P Frick,et al. Diagnostic efficacy of PET-FDG imaging in solitary pulmonary nodules. Potential role in evaluation and management. , 1993, Chest.
[11] H. Malcolm Hudson,et al. Accelerated image reconstruction using ordered subsets of projection data , 1994, IEEE Trans. Medical Imaging.
[12] N. Gupta,et al. Positron emission tomography of lung tumors and mediastinal lymph nodes using [18F]fluorodeoxyglucose. The Members of the PET-Lung Tumor Study Group. , 1994, The Annals of thoracic surgery.
[13] Jeffrey A. Fessler. Penalized weighted least-squares image reconstruction for positron emission tomography , 1994, IEEE Trans. Medical Imaging.
[14] R. Wahl,et al. Staging of mediastinal non-small cell lung cancer with FDG PET, CT, and fusion images: preliminary prospective evaluation. , 1994, Radiology.
[15] J M Hoffman,et al. Semiquantitative and visual analysis of FDG-PET images in pulmonary abnormalities. , 1994, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[16] K Wienhard,et al. The ECAT EXACT HR: Performance of a New High Resolution Positron Scanner , 1994, Journal of computer assisted tomography.
[17] M. Mandelkern,et al. Fluorodeoxyglucose-positron emission tomography in the detection and staging of lung cancer. , 1996, American journal of respiratory and critical care medicine.
[18] J. Sunderland,et al. Mediastinal lymph node staging of non-small-cell lung cancer: a prospective comparison of computed tomography and positron emission tomography. , 1996, The Journal of thoracic and cardiovascular surgery.
[19] E. Gunel,et al. Probability of malignancy in solitary pulmonary nodules using fluorine-18-FDG and PET. , 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[20] G. V. von Schulthess,et al. Non-small cell lung cancer: nodal staging with FDG PET versus CT with correlative lymph node mapping and sampling. , 1997, Radiology.
[21] J Bogaert,et al. Lymph node staging in non-small-cell lung cancer with FDG-PET scan: a prospective study on 690 lymph node stations from 68 patients. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[22] R. Wahl,et al. Oncologic diagnosis with 2-[fluorine-18]fluoro-2-deoxy-D-glucose imaging: dual-head coincidence gamma camera versus positron emission tomographic scanner. , 1998, Radiology.
[23] D Delbeke,et al. Prospective investigation of positron emission tomography in lung nodules. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[24] M. Schwaiger,et al. Controlled prospective study of positron emission tomography using the glucose analogue [18F]fluorodeoxyglucose in the evaluation of pulmonary nodules , 1998, The British journal of surgery.
[25] J S Karp,et al. Whole-body positron emission tomography for oncology imaging using singles transmission scanning with segmentation and ordered subsets-expectation maximization (OS-EM) reconstruction. , 1998, European journal of nuclear medicine.
[26] K Kubota,et al. Lesion-to-background ratio in nonattenuation-corrected whole-body FDG PET images. , 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[27] C. Mountain,et al. The international system for staging lung cancer. , 2000, Seminars in surgical oncology.